跳至主要内容
临床试验/PACTR202404890252448
PACTR202404890252448招募中Unknown

A pilot pre- post trial of the feasibility, acceptability, tolerability, and efficacy of accelerated bilateral theta-burst stimulation for depression in adults with HIV in South Africa

Faculty of Medicine and Health Sciences0 个研究点目标入组 10 人开始时间: 2024年3月28日最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Adults (= 18 years) diagnosed with HIV
  • On ART for an uninterrupted period of at least six months
  • Current comorbid MDD diagnosis confirmed by a diagnostic interview.
  • Able to attend the treatment and monitoring visits at the university campus during office hours.
  • Able to provide written informed consent.
  • For participants on psychotropic medication, a stable dose (=2 months) will be required before the pre-treatment assessment. These participants will continue with their current treatment regimens for the duration of their trial participation.
  • Participants will also be required not to engage in other interventions (i.e., psychotherapy) during the study
  • period (six weeks from pre-treatment to one-month follow-up).

排除标准

  • Known with life-threatening medical illnesses (e.g., cancer), or serious psychiatric conditions (e.g., psychosis, mania).
  • Participants with specific TMS-associated contraindications (e.g., metal implants close to the skull area or uncontrolled epilepsy) will also be excluded.

研究者

相似试验